medical nutrition therapy

  1. It refers to a comprehensive nutritional assessment based on identified client needs upon which therapeutic treatment of disease processes can be based. It is provided by a dietician in conjunction with collaborative management by health care providers.
    Medical Nutrition Therapy (MNT)
  2. It is used to correct & replace nutrient deficiencies and provide adequate nutrition for clients with defined health problems.
    Medical Nutritional Therapy
  3. It is important to include nutrition as a part of a sound foundation on which to base identified needs, expected outcomes, and response to treatments.
    First-Line Treatment
  4. Dietary factors greatly influence disease risk and progression.

    True or False?
    True
  5. A stable _____ within range of IBW is associated with a decreased risk
    of disease progression
    weight pattern
  6. Indications for Nutritional Support
    • • Client physical conditions
    • • Therapeutic bowel rest
    • • Severe PCM/PEM
  7. Types of Support Methods
    • 1. Oral Supplement
    • 2. Tube Feedings
    • 3. Tube Enterostomy
    • 4. Parenteral Nutrition
  8. Provides calories & nutrients; In liquid or powdered form & are usually packaged in ready-to-use formulations; Is categorized into 4 types according to formula types.
    Oral Supplement
  9. One nutrient source; Not nutritionally complete by themselves; Considered to be nutrient dense without increasing volume

    Selection
    CHO – Moducal, Nutrisource CHO, Polycosem Sumacal
    Lipids – MCT – Microlipid
    Protein – ProMod, Propac, Pro-MT, Casec
    • Modular supplements
    • (3.8-4.0 kcal/ml)
  10. Essential nutrient in a specific volume based on a specified formulation; Contains intact proteins of high biologic value, complex CHOs, fats, vitamins, minerals, & trace elements

    Selection: Ensure, Sustacal, Resource, Meritene 
    (Diabetic clients can have intact formulas that address specific glucose requirements.)
    • Polymeric (intact protein)
    • (1-2 kcal/ml)
  11. Provides nutrients in predigested form, making their transport & absorption easier in the body

    Selection: Flexical, Vital, Vivonex
    (Lactose-free, non palatable, & hyperosmolar – best given by enteral administration.)
    • Elemental (predigested/hydrolyzed)
    • (1-1.3 kcal/ml)
  12. Provides formulation specific to metabolic requirements

    Selection:
    Liver – Hepatic-Aid
    Pulmonary – Pulmocare
    Renal – Travasob Rena
    Disease-specific
  13. Clinical indications:
    • Condition that prevents food intake (e.g., swallowing & chewing problems, mouth infections)
    • Disease state that prevents/limits food absorption (e.g., intestinal disease, malabsorptive states)
    • Increase metabolic needs when oral intake cannot meet needed nutrient requirements (e.g., malnutrition, burns, & trauma)
    Tube Feedings
  14. Site selections for tube feedings
    • NG – nasogastric tube
    • ND – nasoduodenal tube
    • NJ – nasojejunal tube
  15. Involves placement of tubes through a surgical opening to provide nutrient/fluid intake and is indicated to specific malabsorptive problems requiring long-term
    therapy
    Tube Enterostomy
  16. Site selections for tube enterostomy
    • PEG tube – percutaneous endoscopic gastrostomy
    • PEJ tube – percutaneous endoscopic jejunostomy
  17. Nutrients/fluids are delivered through the parenteral route to maintain adequate
    metabolic balance.
    Parenteral Nutrition
  18. Site Selections for parenteral nutrition
    • • PPN – peripheral parenteral nutrition
    • • TPN – total parenteral nutrition
  19. Nutritional requirements for clients with supportive methods
    • • Macronutrients
    • • Micronutrients
    • • Water
  20. Members of the healthcare team
    • • Physician
    • • Dietician
    • • Nurse
    • • Client & Family
  21. It refers to a method of feeding clients who have a functioning GI tract but are unable to take a diet orally or whose diet is inadequate.
    Enteral Nutrition
  22. Enteral feedings can be delivered either ___ or via a ___ placement.
    orally; tube
  23. Indications for short-term
    via nasogastric tubes or oral route
  24. Indications for long-term
    via enterostomy place surgically or percutaneously
  25. Clinical indications
    • Condition that prevents food intake (e.g., swallowing & chewing problems,
    mouth infections)
    • Disease state that prevents/limits food absorption (e.g., intestinal disease,
    malabsorptive states)
    • Increase metabolic needs when oral intake cannot meet needed nutrient
    requirements (e.g., malnutrition, burns, & trauma)
    Enteral Nutrition
  26. types of feeding
    • -continuous 
    • -discontinuous:
    •    > cyclic
    •    > intermittent
    •    > bolus
  27. EN via feeding pump for <24h/day
    Cyclic
  28. EN via feeding pump for 24h/day
    Continuous
  29. EN over 20-60 mins q4-6h with/without feeding pump
    Intermittent
  30. EN over short time period at specified interval via gravity drip or syringe
    Bolus
  31. Characteristics of formula
    • • Protein classification
    • • Nutrient density
    • • Amounts of residue and fiber
  32. How to estimate nasogastric tube length
    Image Upload 2
  33. EN: Check placement of tube prior to any feeding, flush, or medications administration by:
    • • Aspiration of gastric contents
    • • Introduction of air with auscultation
    • • X-ray
  34. EN: Position the client to ____ to ____ position.
    semi-fowlers; high-fowler’s
  35. EN: How many mL should be used to flush the tube before and after feedings
    30-50ml
  36. EN: Irrigate tubes every ___ H
    6-8
  37. Arrange the following: 
    1. Image Upload 4
    2. Image Upload 6
    3. Image Upload 8
    2, 3, 1
  38. EN: Medications must be of ____ form. Crush tablet-form medications (refer to pharmacist). Flush with 20cc of water.
    liquid
  39. EN: It is important to incorporate the concepts of altered nutritional status & body image in developing plan of care.

    True or False?
    True
  40. Parameters to monitor in EN
    • • Tube placement
    • • Urine glucose q shift
    • • Gastric residuals q 4H
    • • BM and consistency
    • • Tolerance to feedings
    • • Record daily weight and I&O
  41. Parameters needed to monitor and record weekly
    • • Serum e- and blood counts
    • • Chemistry profile
    • • Nitrogen balance
  42. Possible complications in EN
    • • Mechanical - Clogged tube, Tube dislodgment, Defected infusion pump
    • • Metabolic - DHN, E- imbalances, Altered blood glucose levels
    • • Formula-related - Diarrhea, Cramps, Abdominal distention, Constipation, Nausea, Vomiting
    • • Dermatologic - Skin irritation, infection
  43. It is the administration of nutrients by a route other than the GI tract, usually intravenously.
    Parenteral Nutrition
  44. 2 Types of Parenteral Nutrition
    • a. Total Parenteral Nutrition (TPN)
    • b. Peripheral Parenteral Nutrition (PPN)
  45. Osmolality: > 10% 
    GIT: Non-functional 
    IV sites: Superior Vena Cava, Subclavian vein
    Access: Central line /PICC 
    Indications for use: Long-term
    Total Parenteral Nutrition (TPN)
  46. Osmolality: Isotonic solutions - <10% dextrose, <5% amino acids
    GIT: Functional
    IV sites: Peripheral vein
    Access: Peripheral line
    Indications for use: Short-term
    Peripheral Parenteral Nutrition (PPN)
  47. PN: List of Nutrients
    • • Dextrose (Carbohydrate source)
    • • Amino acids (protein source)
    • • Lipids (fat source)
    • • Water
    • • Electrolytes
    • • Micronutrients
    • • Vitamins
    • • Additives
  48. Nutrient needs are calculated by ___.
    RND
  49. Lipid emulsions are added to dextrose and amino acid mixtures; Also called as 3-in-1 mixture; Advantage: allows infusion over 24 hours
    Total Nutrient Admixture (TNA)
  50. PN: All nutrients are mixed in the same IV bag, except for lipids.
    2 in 1
  51. PN: All nutrients are mixed in the same IV bag to form a lipid emulsion.
    3 in 1
  52. Run TPN through a ____.
    dedicated line
  53. Inspect TPN products prior to hanging for “_____” (lipid separation). Do not hang if it is present. Return it to the pharmacy.
    cracking
  54. Infuse TPN using an _____ per protocol
    infusion pump
  55. When client is progressing and TPN therapy is to be stopped, follow protocol for discontinuing therapy. DO NO STOP TPN ABRUPTLY – It can cause _______.
    rebound hypoglycemia
  56. When enteral feedings are being tolerated by the patient (60% of caloric intake), the client is ready to be taken off from TPN.

    True or False?
    True
  57. May cause permanent damage to the soft tissue around the IV site; thus, immediate intervention should be done.
    IV Infiltration
  58. TPN: Parameters to Monitor (q8h, daily, weekly)
    • • Every 8h - VS, Urine fractionals
    • • Daily - Wt, I&O, Serum e-, glucose, crea, BUN
    • until stable; then twice weekly
    • • Weekly - Serum Mg, Ca, Ph, Albumin, Liver function Tests, CBC, Review of actual, oral, enteral, and TPN intake
  59. TPN: Complications
    • • Catheter-related - Occlusion due to thrombosis, Development of air embolism, and Incorrect placement
    • • Metabolic-related - Acid-base imbalances, E-imbalances, Nutrient deficiencies, DHN, Fluid retention
  60. Common Hospital Diets (GTLMH)
    • - 1600 KCl in 6 divided feedings Diabetic diet
    • - Soft diet
    • - DAT NDCF (No Dark Colored Foods)
    • - Low salt, Low Fat
    • - DM Diet
    • - DAT with SAP
    • - No Dark colored foods
    • - Low Purine Diet
    • - LSLF, DM Diet (Low salt, Low fat)
    • - NPO
    • - Soft diet with sap,npo if dyspneic
    • - LSLF No fruits in diet
    • - Renal diet
    • - DAT
    • - NPO
    • - BF- Breastfeeding
    • - DIET FOR AGE WITH AP
    • -DFA
    • - OF (Osteorized Feeding) OF 760N KCAL 4 FEEDINGS POTASSIUM RICH FOODS 1 BANANA PER MEAL DAT EXCEPT DARK COLORED FOODS 1500 KCAL/ DAY DIVIDED INTO 4 FEEDINGS 1 BANANA/ MEAL
    • - DAT NCCF
    • - OF- Osteorized Feeding/ Blenderized Feeding
Author
qrysh
ID
363717
Card Set
medical nutrition therapy
Description
Updated